St. Louis Financial Planners Asset Management LLC Purchases New Holdings in Astera Labs, Inc. $ALAB

St. Louis Financial Planners Asset Management LLC bought a new position in Astera Labs, Inc. (NASDAQ:ALAB) in the 3rd quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm bought 2,704 shares of the company’s stock, valued at approximately $963,000.

A number of other institutional investors and hedge funds have also modified their holdings of ALAB. Mosley Wealth Management increased its stake in shares of Astera Labs by 12.7% in the third quarter. Mosley Wealth Management now owns 497 shares of the company’s stock worth $177,000 after acquiring an additional 56 shares during the last quarter. Howard Capital Management LLC acquired a new stake in Astera Labs during the third quarter valued at $1,112,000. NFSG Corp boosted its position in Astera Labs by 83.0% during the third quarter. NFSG Corp now owns 10,623 shares of the company’s stock valued at $3,781,000 after purchasing an additional 4,818 shares during the last quarter. Assenagon Asset Management S.A. boosted its position in Astera Labs by 886.9% during the third quarter. Assenagon Asset Management S.A. now owns 74,746 shares of the company’s stock valued at $26,607,000 after purchasing an additional 67,172 shares during the last quarter. Finally, State of Alaska Department of Revenue grew its stake in Astera Labs by 6.4% in the third quarter. State of Alaska Department of Revenue now owns 2,507 shares of the company’s stock valued at $892,000 after purchasing an additional 150 shares in the last quarter. Hedge funds and other institutional investors own 60.47% of the company’s stock.

Analyst Upgrades and Downgrades

Several equities analysts recently weighed in on the stock. Northland Securities lowered shares of Astera Labs from an “outperform” rating to a “market perform” rating in a research report on Friday, October 9th. Weiss Ratings upgraded shares of Astera Labs from a “hold (c)” rating to a “buy (b-)” rating in a research note on Thursday, October 8th. Royal Bank Of Canada boosted their target price on shares of Astera Labs from $425.00 to $500.00 and gave the stock an “outperform” rating in a research report on Wednesday, August 5th. Barclays increased their price target on shares of Astera Labs from $200.00 to $325.00 and gave the stock an “equal weight” rating in a research note on Monday, July 20th. Finally, Needham & Company LLC raised their price target on shares of Astera Labs from $260.00 to $425.00 and gave the company a “buy” rating in a report on Wednesday, August 5th. Eleven equities research analysts have rated the stock with a Buy rating and ten have assigned a Hold rating to the company. According to MarketBeat, the stock currently has an average rating of “Moderate Buy” and a consensus price target of $348.33.

Insider Transactions at Astera Labs

In other Astera Labs news, Director Stefan Dyckerhoff sold 8,994 shares of the business’s stock in a transaction dated Wednesday, September 2nd. The shares were sold at an average price of $274.96, for a total value of $2,472,990.24. Following the transaction, the director directly owned 3,309 shares in the company, valued at $909,842.64. The trade was a 73.10% decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, Director Manuel Alba sold 183,000 shares of the stock in a transaction that occurred on Tuesday, September 1st. The stock was sold at an average price of $280.13, for a total value of $51,263,790.00. Following the sale, the director owned 253,863 shares in the company, valued at approximately $71,114,642.19. This trade represents a 41.89% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Over the last 90 days, insiders sold 408,558 shares of company stock valued at $127,306,034. 10.40% of the stock is owned by company insiders.

Astera Labs Trading Down 5.4%

NASDAQ ALAB traded down $16.16 on Friday, reaching $285.82. The company’s stock had a trading volume of 4,159,250 shares, compared to its average volume of 4,402,957. The firm has a market cap of $49.59 billion, a PE ratio of 141.50 and a beta of 3.68. The business has a 50-day moving average price of $314.86 and a 200 day moving average price of $297.01. Astera Labs, Inc. has a 52 week low of $97.89 and a 52 week high of $499.48.

Astera Labs (NASDAQ:ALAB) last announced its quarterly earnings results on Tuesday, August 4th. The company reported $0.80 earnings per share for the quarter, beating analysts’ consensus estimates of $0.69 by $0.11. Astera Labs had a return on equity of 19.24% and a net margin of 30.74%. The firm had revenue of $392.40 million for the quarter, compared to analysts’ expectations of $360.85 million. During the same period in the prior year, the business posted $0.44 earnings per share. The business’s revenue was up 104.5% compared to the same quarter last year. Astera Labs has set its Q3 2026 guidance at 1.160-1.210 EPS. Analysts anticipate that Astera Labs, Inc. will post 2.70 earnings per share for the current fiscal year.

Astera Labs Company Profile

Astera Labs, Inc is a fabless semiconductor company that develops connectivity solutions for cloud and artificial intelligence infrastructure. Its products are designed to help data centers connect and manage processors, memory, storage, and networking components in high-performance computing systems.

The company’s portfolio includes Aries PCI Express and Compute Express Link (CXL) smart memory controllers, Scorpio PCIe switches, Taurus Ethernet fabric switches, and Leo CXL memory connectivity products.